logo
15:58 Dec 05

Zim Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
71.41
+0.41 (+0.58%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zim Laboratories Ltd. Financials

Zim Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
71.41
+0.41 (+0.58%)
15:58 Dec 05
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

49/100
Mid Valuation

Technical

30/100
Technically Bearish

Strength

4

Weakness

15

Opportunity

0

Threats

0

4.82 %

ROE %

2.57 %

ROA %

1.35

EPS

51.77

BVPS

3.20 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
333.43 398.53 367.42 379.03 365.53
Operating Expenses +
292.45 346.54 326.1 335.31 329.37
Raw Material
170.02 182.37 185.5 166.58 169.91
Increase Decrease in Cost
-9.67 16.46 -14.05 1.27 -10.73
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
40.07 49.32 53.34 60.76 61.72
Miscellaneous Expenses
110.85 133.17 116.91 129.86 108.47
Operating Profit
40.98 51.99 41.32 43.72 36.16
Other Income
4.4 6.41 5.18 5.78 6.98
Depreciation
16.03 17.47 15.95 20.11 20.01
Interest
8.31 5.58 6.92 11.39 12.1
Profit before tax and exceptio..
21.04 35.36 23.64 18.01 11.03
Exceptional Items
0 0 0 0 0
PBT
21.04 35.36 23.64 18.01 11.03
Provision for Taxation
6.49 10.92 6.4 5.84 4.44
Net Profit
14.55 24.43 17.25 12.16 6.59
NET Profit after MI
14.55 24.43 17.25 12.17 6.59
EPS
8.96 5.01 3.54 2.5 1.36
Operating Profit Margin (%)
12.29 13.05 11.25 11.53 9.89
Net Profit Margin (%)
4.36 6.13 4.69 3.21 1.8

Zim Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 33.30 33.30 33.30 33.30 33.30 33.30
FII 0.00 0.00 0.00 0.20 0.00 0.00
Public 0.20 0.30 0.20 0.20 0.10 0.10
Others 66.50 66.40 66.50 66.30 66.60 66.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: